OLUTASIDENIB vs OMALIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OLUTASIDENIB vs OMALIZUMAB: Safety Overview
| Metric | OLUTASIDENIB | OMALIZUMAB |
|---|---|---|
| Total FAERS Reports | 210 | 63,846 |
| Deaths Reported | 27 | 1,713 |
| Death Rate | 12.9% | 2.7% |
| Hospitalizations | 85 | 11,178 |
| Average Patient Age | 66.2 yrs | 51.0 yrs |
| % Female Patients | 46.3% | 72.5% |
| FDA Approval Date | Dec 1, 2022 | N/A |
| Manufacturer | Rigel Pharmaceuticals, Inc. | CELLTRION, Inc. |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |